| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.37 | 9e-13 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-10 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-09 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.29 | 5e-08 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.23 | 6e-06 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-06 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |